Simple change in injection technique could spare heart patients pain and bruising

NCT ID NCT06776159

Recruiting now Symptom relief Sponsor: The Hong Kong Polytechnic University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether a standardized, step-by-step protocol for giving blood thinner injections (low-molecular-weight heparin) can reduce bruising and pain in heart patients. About 180 patients in cardiac care units will be randomly assigned to receive injections either by the usual method or by the new standard protocol. The goal is to see if consistent best practices lead to fewer injection-site complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: low-molecular-weight heparin (LMWH)
What this could lead to: If successful, this could lead to a simple, standardized way to give blood thinner injections that causes less bruising and pain for heart patients.
What could go wrong: This is a small, early-stage trial focused on injection technique, not a new drug. The results may not apply to all patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRUISE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiovascular disorder Contusions Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BRUISE CVD - CARDIOVASCULAR DISEASE PAIN

Contacts and locations

Locations

Hospital Authority, Hong Kong
RECRUITING

Hong Kong, 00000, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.